Concentrations of plasma-borne extracellular particles differ between multiple sclerosis disease courses and compared to healthy controls

Abels, 2016, Introduction to Extracellular Vesicles: biogenesis, RNA Cargo Selection, Content, Release, and Uptake, Cell. Mol. Neurobiol., 36, 301, 10.1007/s10571-016-0366-z Alberro, 2019, T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians, Aging, 11, 10723, 10.18632/aging.102517 An, 2013, Exosomes neutralize synaptic-plasticity-disrupting activity of Abeta assemblies in vivo, Mol. Brain, 6, 47, 10.1186/1756-6606-6-47 Butzkueven, 2006, MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis, Mult. Scler. J.12, 769, 10.1177/1352458506070775 Clark, 2016, Nomenclature of CD molecules from the Tenth Human Leucocyte Differentiation Antigen Workshop, Clin. Transl. Immunol., 5, e57, 10.1038/cti.2015.38 Danesh, 2014, Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro, Blood, 123, 687, 10.1182/blood-2013-10-530469 Dendrou, 2015, Immunopathology of multiple sclerosis, Nat. Rev. Immunol.15, 545, 10.1038/nri3871 Dickens, 2017, Astrocyte-shed extracellular vesicles regulate the peripheral leukocyte response to inflammatory brain lesions, Sci. Signal., 10, eaai7696, 10.1126/scisignal.aai7696 Dziedzic, 2019, Interactions between platelets and leukocytes in pathogenesis of multiple sclerosis, Adv. Clin. Exp. Med., 28, 277, 10.17219/acem/83588 Enjeti, 2016, Correlative analysis of nanoparticle tracking, flow cytometric and functional measurements for circulating microvesicles in normal subjects, Thromb. Res., 145, 18, 10.1016/j.thromres.2016.06.029 Enjeti, 2017, Circulating microvesicle number, function and small RNA content vary with age, gender, smoking status, lipid and hormone profiles, Thromb. Res., 156, 65, 10.1016/j.thromres.2017.04.019 García-Romero, 2017, DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients, Oncotarget, 8, 1416, 10.18632/oncotarget.13635 Groen, 2016, Erythrocytes in multiple sclerosis–forgotten contributors to the pathophysiology, Mult. Scler. J.–Exp. Translat. Clin.2 Hermiston, 2003, CD45: a critical regulator of signaling thresholds in immune cells, Annu. Rev. Immunol., 21, 107, 10.1146/annurev.immunol.21.120601.140946 Iwai, 2017, Isolation of Extracellular Vesicles in Saliva Using Density Gradient Ultracentrifugation, Methods Mol. Biol., 1660, 343, 10.1007/978-1-4939-7253-1_27 Jelcic, 2018, Memory B Cells Activate Brain-Homing, Autoreactive CD4(+) T Cells in Multiple Sclerosis, Cell, 175, 85, 10.1016/j.cell.2018.08.011 Jy, 2004, Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis, Front. Biosci., 9, 3137, 10.2741/1466 Lublin, 2014, Defining the clinical course of multiple sclerosis: the 2013 revisions, Neurology, 83, 278, 10.1212/WNL.0000000000000560 Mantel, 2016, Infected erythrocyte-derived extracellular vesicles alter vascular function via regulatory Ago2-miRNA complexes in malaria, Nat. Commun., 7, 12727, 10.1038/ncomms12727 Marcos-Ramiro, 2014, Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function, BMC Neurosci., 15, 110, 10.1186/1471-2202-15-110 Matsumoto, 2017, The transport mechanism of extracellular vesicles at the blood-brain barrier, Curr. Pharma. Des.23, 6206 Matsumoto, 2017, Transmission of alpha-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson’s disease?, Acta, Neuropathol, Commun,, 5, 71, 10.1186/s40478-017-0470-4 Minagar, 2001, Elevated plasma endothelial microparticles in multiple sclerosis, Neurology, 56, 1319, 10.1212/WNL.56.10.1319 Norton, 2010, Position statement on physical activity and exercise intensity terminology, J. Sci. Med. Sport13, 496, 10.1016/j.jsams.2009.09.008 Pisitkun, 2004, Identification and proteomic profiling of exosomes in human urine, Proc. Natl. Acad. Sci. U.S.A., 101, 13368, 10.1073/pnas.0403453101 Ridder, 2014, Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation, PLoS ONE, 12 Romme Christensen, 2013, Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression, PLoS ONE, 8, e57820, 10.1371/journal.pone.0057820 Saenz-Cuesta, 2014, Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis, Biomark. Med., 8, 653, 10.2217/bmm.14.9 Saenz-Cuesta, 2014, Extracellular Vesicles in Multiple Sclerosis: what are They Telling Us?, Front. Cell. Neurosci., 8, 100, 10.3389/fncel.2014.00100 Selmaj, 2017, The role of exosomes in CNS inflammation and their involvement in multiple sclerosis, J. Neuroimmunol., 306, 1, 10.1016/j.jneuroim.2017.02.002 Sheremata, 2006, Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis, J. Neuroinflam.3, 23, 10.1186/1742-2094-3-23 Sheremata, 2008, Evidence of platelet activation in multiple sclerosis, J. Neuroinflam.5, 27, 10.1186/1742-2094-5-27 Thery, 2018, Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines, J. Extracell. Vesicles, 7, 10.1080/20013078.2018.1535750 Thompson, 2018, Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria, Lancet Neurol., 17, 162, 10.1016/S1474-4422(17)30470-2 Vyshkina, 2004, CD45 (PTPRC) as a candidate gene in multiple sclerosis, Mult. Scler., 10, 614, 10.1191/1352458504ms1115oa Zaborowski, 2015, Extracellular Vesicles: composition, Biological Relevance, and Methods of Study, Bioscience, 65, 783, 10.1093/biosci/biv084 Zinger, 2016, Plasma levels of endothelial and B-cell-derived microparticles are restored by fingolimod treatment in multiple sclerosis patients, Mult. Scler., 22, 1883, 10.1177/1352458516636959